Workflow
手术导航机器人
icon
Search documents
2025年中国AI医疗器械行业产业链图谱、产业环境、市场规模及未来趋势研判:产业发展环境不断优化,AI医疗器械获批上市数量日益增多[图]
Chan Ye Xin Xi Wang· 2025-06-30 01:15
Core Viewpoint - The AI medical device industry in China is experiencing rapid growth driven by policy support, technological advancements, and market demand, with the market size projected to reach 242.3 billion yuan by 2025, up from 94.61 billion yuan in 2024 and 2.92 billion yuan in 2020 [1][12]. Industry Overview - AI medical devices utilize artificial intelligence to assist in diagnosis, monitoring, and optimizing medical processes, categorized into six main types: medical imaging analysis, diagnostic assistance systems, surgical robots, health monitoring devices, drug development tools, and personalized treatment systems [2][4]. - The industry has formed a multi-dimensional ecosystem involving traditional healthcare providers, internet companies, AI algorithm developers, and medical device manufacturers, creating a closed-loop industry ecology [4]. Industry Environment - The AI chip market, crucial for the smart capabilities of medical devices, is projected to reach 141.2 billion yuan in 2024, growing by 17.1% year-on-year, providing strong technical support for the AI medical device sector [6]. - The machine vision market, which enhances the precision of medical devices, is expected to grow to 207.17 billion yuan in 2024, with an 11.9% increase, indicating significant advancements in this technology [8]. Social Environment - The aging population and uneven distribution of medical resources in China are driving strong demand for AI medical devices, which play a vital role in early disease screening and long-term monitoring [10]. - There is a growing consumer demand for personalized services, prompting AI medical devices to focus on customized offerings through deep learning and big data analysis [10]. Current Industry Status - The AI medical device industry in China is in its early commercialization stage, with a significant increase in product approvals, as evidenced by a 50% year-on-year rise in the number of approved Class III AI medical devices in 2023 [14]. - By mid-2024, 92 Class III AI medical imaging products had been approved, covering various diseases such as cardiovascular, pulmonary, and neurological conditions [14]. Competitive Landscape - Leading companies in the AI medical device sector include United Imaging, Pushang Medical, and Sukun Technology, each leveraging core technology and deep integration with clinical scenarios to establish a differentiated competitive landscape [16]. - United Imaging leads the market with a comprehensive product line and strong partnerships with top-tier hospitals, while Pushang Medical and Sukun Technology focus on specific areas like lung AI imaging and cardiovascular AI [16][17]. Future Trends - The industry is expected to see enhanced technological innovation and accelerated product iterations, driven by advancements in deep learning and computer vision [22]. - Market competition is intensifying, with companies adopting differentiated strategies in niche areas, particularly in medical imaging [23]. - The internationalization of Chinese AI medical device companies is accelerating, facing global competition and regulatory challenges as they expand into overseas markets [25].
测血糖不用扎指尖、机器人走上手术台,一批医疗创新成果亮相丰台
Xin Jing Bao· 2025-06-26 07:57
据丰台区医药大健康专班执行召集人毛山宏介绍,自去年5月首届智能医工大会举办以来,丰台区组建 了医药大健康产业专班,200多位顶尖专家组成专家委员会。同时,建立医药大健康创新服务中心,引 入天坛国际脑健康中心、西门子医疗首个开放式医工转化平台等一批企业和机构,已推动一批创新产品 实现临床应用。 以脑血管介入术为例,传统造影术需要医护人员身着铅衣、铅围脖才能进行,有了手术机器人,医生在 手术间外的操作台前,通过操作手柄控制机械臂即可完成手术,解决了血管介入术医生受辐射损伤的临 床痛点。该机器人取得我国首张三类医疗器械注册证,已在国内多家三甲医院完成临床验证。 在无创血糖仪展台前,糖尿病患者郑女士体验了无创血糖检测。与传统的指尖采血检测相比,该检测无 痛感,且准确性更高。据介绍,无创血糖仪采用代谢热整合法技术,通过多传感器集成实现血糖无创检 测,检测结果与静脉血一致性达94.5%。 新京报讯(记者姜慧梓)手术机器人、无创血糖仪、AI热疗仪、手术导航机器人……6月26日,一批医 疗领域创新成果在天坛智能医工产业园亮相。 当天,2025中关村论坛系列活动——"智能医工创新发展论坛"暨丰台区第二届智能医工产业创新发展大 ...
青岛加速布局具身智能机器人产业 打造北方创新高地重要研制中心
Huan Qiu Wang· 2025-06-11 08:26
在医疗领域,山东卓业医疗科技有限公司同样成绩斐然。其研发的全球首台AI经皮穿刺手术导航机器 人,将穿刺手术精度提升至亚毫米级,实现精准微创治疗领域重大突破,并已通过国家药监局三类医疗 器械认证。据该公司研发经理郭永介绍,依托3D结构光扫描技术,机器手臂能精准测算穿刺路径和深 度,大幅降低支气管、近血管等复杂位点穿刺手术风险。目前,企业正深入推进AI技术与手术机器人 融合,推动其在肿瘤微创、脊柱微创和神外微创等多场景应用。 具身智能机器人融合芯片、传感器、软件等众多前沿技术,产业链协同至关重要。目前,青岛市已初步 构建起"大小脑、本体、零部件、场景应用"全覆盖的产业链条。其中,关键零部件企业表现亮眼:国华 (青岛)智能装备有限公司自主研发的谐波减速器性能达国际先进水平,兼具高性能、个性化定制与价 格优势,客户涵盖宇树科技等头部企业;海克斯康智能制造技术(青岛)有限公司推出的软件和激光跟 踪仪,为人形机器人提供校准方案,有效提升其运动精度和性能,相关技术和解决方案已在多行业场景 验证应用。 在应用场景拓展方面,青岛企业成果丰硕。早在10年前,海尔便成立机器人公司,围绕工厂与家庭服务 场景探索,推出洗护、陪伴、外骨 ...
从科幻到现实,青岛具身智能机器人产业如何突围
Qi Lu Wan Bao Wang· 2025-05-15 07:39
齐鲁晚报·齐鲁壹点 尚青龙 乐聚智家"夸父"以高情商互动讲解引人驻足;优必选Walker S作为新"员工"进驻工厂参与实训;海尔家 庭服务机器人开启"无人家务"的智慧生活……这些场景已非科幻电影的遐想,而是青岛机器人产业蓬勃 发展的真实缩影。5月14日,2025青岛市具身智能机器人生态发展大会启幕。会上发布的《青岛市具身 智能机器人产业2025年行动方案》勾勒出清晰蓝图,高端智库、产业发展联盟的成立,百亿基金的发 起,彰显这座制造业名城的"造机"雄心——以"机器人总动员"之势,布局当下最火产业赛道。 为科幻变为现实找可能 让机器人真正成为"伙伴" 关于智能机器人,在科幻大片中,它不仅仅是执行指令的"工具人",更是能交流情感、主动解决问题的 生活伙伴。在2025青岛市具身智能机器人生态发展大会现场,青岛多家具身智能机器人产业代表企业展 示了在这一赛道上的最新成果,探索这一愿景变为现实的可能性。 作为跑过马拉松的明星机器人,"夸父"机器人现场亮相吸引了众多关注。它不仅能够灵活地双腿行走, 精准执行手部的抓、握等指令,还能进行自然流畅的对话。乐聚机器人团队表示,在人类看来举手之劳 的动作,机器人要做到,涉及复杂的算 ...